title: Invasive pneumococcal disease in England and Wales: vaccination implications.
abstract: Knowledge of the epidemiology of invasive pneumococcal disease (IPD) will aid in planning the use of pneumococcal vaccines. A United Kingdom (UK)-based surveillance in England and Wales (1995-1997) of 11,528 individuals with IPD and a local enhanced surveillance in the Oxford (UK) area (1995-1999) have been analyzed. IPD has a high attack rate in children, with 37.1-48.1 cases per 100,000 infants <1 year old per year, and in older persons, with 21.2-36.2 cases per 100,000 persons >65 years old per year, for England, Wales, and Oxford. The 7-valent conjugate vaccine includes serotypes causing < or =79% of IPD in children <5 years old, but only 66% in adults >65 years old. The data also indicate that IPD varies by serotype, age, and country, emphasizing that the epidemiology of IPD is heterogeneous and requires continued surveillance.
authors: Oxford Vaccine Group, John Radcliffe Hospital, Oxford, United Kingdom.
authors: K
authors: K
authors: Sleeman
authors: K
authors: K
authors: Knox
authors: R
authors: R
authors: George
authors: E
authors: E
authors: Miller
authors: P
authors: P
authors: Waight
authors: D
authors: D
authors: Griffiths
authors: A
authors: A
authors: Efstratiou
authors: K
authors: K
authors: Broughton
authors: R T
authors: RT
authors: Mayon-White
authors: E R
authors: ER
authors: Moxon
authors: D W
authors: DW
authors: Crook
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D004739:England / Q000453:epidemiology; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011008:Pneumococcal Infections / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000276:immunology; D012703:Serotyping; D013296:Streptococcus pneumoniae / Q000145:classification* / Q000302:isolation & purification; D014611:Vaccination; D018074:Vaccines, Conjugate / Q000276:immunology; D014852:Wales / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents; D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate